Fetuin-A in Infants Born Small- or Large-for-Gestational-Age

Area of Science:

• Perinatology
• Endocrinology
• Biochemistry

Background:

• Fetuin-A is a glycoprotein known for its roles in insulin resistance and bone metabolism.
• Its potential involvement in fetal growth regulation, specifically poor or excessive fetal growth, remains unclear.

Purpose of the Study:

• To investigate the association between cord plasma fetuin-A concentrations and fetal growth parameters.
• To determine if fetuin-A is linked to small-for-gestational-age (SGA) or large-for-gestational-age (LGA) outcomes.

Main Methods:

• A nested case-control study within the Shanghai Birth Cohort involving 60 trios for SGA, optimal-for-gestational-age (OGA), and LGA infants.
• Measurement of cord plasma fetuin-A and fetal growth factors (insulin, proinsulin, IGF-I, IGF-II).
• Statistical analysis to assess associations and risks, adjusting for confounding factors.

Main Results:

• Cord plasma fetuin-A concentrations were significantly higher in both SGA and LGA newborns compared to OGA newborns.
• Higher fetuin-A levels were associated with increased risks of both SGA and LGA.
• The association between fetuin-A and LGA remained significant after adjusting for covariates, while the SGA association became non-significant.

Conclusions:

• Fetuin-A may play a role in excessive fetal growth (LGA).
• This association appears independent of key fetal growth factors like insulin and IGFs.
• Fetuin-A's role in poor fetal growth (SGA) requires further investigation.